106 related articles for article (PubMed ID: 2397925)
1. 1,25-Dihydroxyvitamin D3 induces normal mononuclear blood cells to differentiate in the direction of monocyte-macrophages.
Choudhuri U; Adams JA; Byrom N; McCarthy DM; Barrett J
Haematologia (Budap); 1990; 23(1):9-19. PubMed ID: 2397925
[TBL] [Abstract][Full Text] [Related]
2. Effect of 1,25(OH)2D3 on normal human CFU-GM: target cells of the agent in the suppression of colony formation and induction of macrophage colonies.
Takahashi T; Suzuki A; Ichiba S; Okuno Y; Sugiyama H; Imura H; Nakamura K; Iho S; Hoshino T
Int J Hematol; 1991 Feb; 54(1):57-63. PubMed ID: 1954352
[TBL] [Abstract][Full Text] [Related]
3. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues.
Koeffler HP; Amatruda T; Ikekawa N; Kobayashi Y; DeLuca HF
Cancer Res; 1984 Dec; 44(12 Pt 1):5624-8. PubMed ID: 6594194
[TBL] [Abstract][Full Text] [Related]
4. Effect of 1,25-dihydroxyvitamin D3 on induction of scavenger receptor and differentiation of 12-O-tetradecanoylphorbol-13-acetate-treated THP-1 human monocyte like cells.
Suematsu Y; Nishizawa Y; Shioi A; Hino M; Tahara H; Inaba M; Morii H; Otani S
J Cell Physiol; 1995 Dec; 165(3):547-55. PubMed ID: 7593234
[TBL] [Abstract][Full Text] [Related]
5. 1,25-Dihydroxyvitamin D3 and the regulation of the differentiation and function of macrophages and granulocytes.
Shezen E; Goldman R
Int J Cell Cloning; 1985 Mar; 3(2):65-80. PubMed ID: 3839007
[TBL] [Abstract][Full Text] [Related]
6. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3.
Miyaura C; Abe E; Suda T; Kuroki T
Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776
[TBL] [Abstract][Full Text] [Related]
7. Effect of 1,25-dihydroxyvitamin D3 and 13-cis-retinoic acid on in vitro hematopoiesis in the myelodysplastic syndromes.
Nagler A; Rikilis I; Tatarsky I; Fabian I
J Lab Clin Med; 1987 Aug; 110(2):237-44. PubMed ID: 3474327
[TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D3 activates secretion of hydrogen peroxide by human monocytes.
Cohen MS; Mesler DE; Snipes RG; Gray TK
J Immunol; 1986 Feb; 136(3):1049-53. PubMed ID: 3079794
[TBL] [Abstract][Full Text] [Related]
9. 1,25-Dihydroxyvitamin D3 inhibits myelopoiesis but not B-lymphopoiesis in long-term bone marrow cultures.
Dorshkind K; Reichel H; Norman AW
Exp Hematol; 1989 Jun; 17(5):436-42. PubMed ID: 2785458
[TBL] [Abstract][Full Text] [Related]
10. Suppressive effect of 1,25(OH)2D3, and glucocorticoids on production of tumor necrosis factor-alpha by human peripheral blood adherent cells.
Katakami N; Nakao Y; Fujita T
Kobe J Med Sci; 1991 Jun; 37(3):179-88. PubMed ID: 1745043
[TBL] [Abstract][Full Text] [Related]
11. 1 alpha, 25-Dihydroxyvitamin D3 augments clonal growth of macrophages from rat bone marrow progenitor cells and modulates their function.
Shezen E; Goldman R
Int J Cell Cloning; 1986 Mar; 4(2):115-25. PubMed ID: 3754272
[TBL] [Abstract][Full Text] [Related]
12. Maturation-dependent regulation of protein kinase C activity by vitamin D3 metabolites in chondrocyte cultures.
Sylvia VL; Schwartz Z; Schuman L; Morgan RT; Mackey S; Gomez R; Boyan BD
J Cell Physiol; 1993 Nov; 157(2):271-8. PubMed ID: 8227160
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of monocyte chemotaxis by 1 alpha,25-dihydroxyvitamin D3. Stimulation of defective migration of AIDS patients.
Girasole G; Wang JM; Pedrazzoni M; Pioli G; Balotta C; Passeri M; Lazzarin A; Ridolfo A; Mantovani A
J Immunol; 1990 Oct; 145(8):2459-64. PubMed ID: 2212648
[TBL] [Abstract][Full Text] [Related]
14. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
15. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
Koeffler HP; Hirji K; Itri L
Cancer Treat Rep; 1985 Dec; 69(12):1399-407. PubMed ID: 2416438
[TBL] [Abstract][Full Text] [Related]
16. Biological activities of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 on human promyelocytic leukemic HL-60 cells: effects of fetal bovine serum and of incubation time.
Okuno S; Inaba M; Nishizawa Y; Morii H
Miner Electrolyte Metab; 1995; 21(1-3):211-6. PubMed ID: 7565452
[TBL] [Abstract][Full Text] [Related]
17. Regulation of TNF-alpha release from bone marrow-derived macrophages by vitamin D.
Abu-Amer Y; Bar-Shavit Z
J Cell Biochem; 1994 Aug; 55(4):435-44. PubMed ID: 7962175
[TBL] [Abstract][Full Text] [Related]
18. Induction of a high phagocytic capability in P388D1, a macrophage-like tumor cell line, by 1 alpha, 25-dihydroxyvitamin D3.
Goldman R
Cancer Res; 1984 Jan; 44(1):11-9. PubMed ID: 6546302
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D affects proliferation of a murine T helper cell clone.
Lacey DL; Axelrod J; Chappel JC; Kahn AJ; Teitelbaum SL
J Immunol; 1987 Mar; 138(6):1680-6. PubMed ID: 3029220
[TBL] [Abstract][Full Text] [Related]
20. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
Miyahara T; Simoura T; Osahune N; Uchida Y; Sakuma T; Nemoto N; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Chiba H; Iba K; Sawada N
Calcif Tissue Int; 2002 Jun; 70(6):488-95. PubMed ID: 12016462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]